Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

PRP may improve fertility treatment success but needs more research for safe use.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Upadacitinib may effectively treat resistant lichen planopilaris.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Polynucleotides improve skin quality and are safe and effective for rejuvenation.

Geranyl acetate can protect skin cells from damage and inflammation caused by para-phenylenediamine.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

The new controlled release PRP therapy shows promise for hair growth in women.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Targeting ornithine decarboxylase can help prevent skin cancer.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

PPAR alpha may help in hair growth and could be a target for treatment.

Androgen receptors help prostate cancer cells grow and resist drugs.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.